The natural history of breast cancer with more than 10 positive nodes
- 30 June 1995
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 169 (6) , 575-579
- https://doi.org/10.1016/s0002-9610(99)80224-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.Journal of Clinical Oncology, 1993
- Pathologic findings from the national surgical adjuvant breast project (protocol 4): Discriminants for 15-year survivalCancer, 1993
- Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapyCancer, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Have Changing Treatment Patterns Affected Outcome for Operable Breast Cancer? Ten-year Follow-up in 1288 Patients, 1965 to 1978Annals of Surgery, 1991
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Comparison of Different Trials of Adjuvant Chemotherapy in Stage II Breast Cancer Using a Natural History Data BaseAmerican Journal of Clinical Oncology, 1987
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Adjuvant therapy of stage II breast cancerBreast Cancer Research and Treatment, 1981
- A computer program for comparing K samples with right-censored dataComputer Programs in Biomedicine, 1972